(Q30421760)

21 June 2017

Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review (English)

1 reference

21 June 2017

1 reference

Alina Isai

1

1 reference

21 June 2017

Julie Durand

2

1 reference

21 June 2017

Steven Le Meur

3

1 reference

21 June 2017

Ana Hidalgo-Simon

4

1 reference

21 June 2017

Xavier Kurz

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

26 September 2012

1 reference

21 June 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

30

1 reference

21 June 2017

49

1 reference

21 June 2017

7123-7129

1 reference

Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Safety review: squalene and thimerosal in vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Influenza vaccine makers seek ways to speed production, boost effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Guillain-Barré syndrome following H1N1 immunization in a pediatric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Acute hemorrhagic edema of childhood after H1N1 immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Cutaneous vasculitis following influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Acute polyarthritis after influenza A (H1N1) immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.032

10.1016/J.VACCINE.2012.09.032

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference